Mutation of the Murine Bloom's Syndrome Gene Produces Global Genome Destabilization

Por Chester, Nicholas, Babbe, Holger, Pinkas, Jan, Manning, Charlene, Leder, Philip
Publicado em 2006

Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies

Por Schönfeld, Kurt, Zuber, Chantal, Pinkas, Jan, Häder, Thomas, Bernöster, Katrin, Uherek, Christoph
Publicado no J Hematol Oncol (2017)

Dual inactivation of Hus1 and p53 in the mouse mammary gland results in accumulation of damaged cells and impaired tissue regeneration

Por Yazinski, Stephanie A., Westcott, Peter M. K., Ong, Kelly, Pinkas, Jan, Peters, Rachel M., Weiss, Robert S.
Publicado em 2009

Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models()...

Por Ponte, Jose F., Ab, Olga, Lanieri, Leanne, Lee, Jenny, Coccia, Jennifer, Bartle, Laura M., Themeles, Marian, Zhou, Yinghui, Pinkas, Jan, Ruiz-Soto, Rodrigo
Publicado no Neoplasia (2016)

Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of TGF-β in a mouse model of breast cancer.

Por Nam, Jeong-Seok, Suchar, Adam M., Kang, Mi-Jin, Stuelten, Christina H., Tang, Binwu, Michalowska, Aleksandra M., Fisher, Larry W., Fedarko, Neal S., Jain, Alka, Pinkas, Jan, Lonning, Scott, Wakefield, Lalage M.
Publicado em 2006

A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells

Por Kovtun, Yelena, Jones, Gregory E., Adams, Sharlene, Harvey, Lauren, Audette, Charlene A., Wilhelm, Alan, Bai, Chen, Rui, Lingyun, Laleau, Rassol, Liu, Fenghua, Ab, Olga, Setiady, Yulius, Yoder, Nicholas C., Goldmacher, Victor S., Chari, Ravi V. J., Pinkas, Jan, Chittenden, Thomas
Publicado no Blood Adv (2018)